• CDC Health Update: Inhalation Anthrax Case Investigation, Pennsylvania, New York City (Centers for Disease Control and Prevention, February 24, 2006)
• Health Alert #5: Inhalational Anthrax in a New York City Resident who works with Untanned Animal Hides (New York City Department of Health and Mental Hygiene, February 24, 2006) 
  • Information for Health Care Providers
    
• Anthrax (New York City Department of Health and Mental Hygiene Bureau of Communicable Disease)
• Anthrax (New York State Department of Health)
• Anthrax Fact Sheet: Patient Self-Monitoring Instruction 10.4 KBs (New York State Department of Health, October 18, 2001)
• Fact Sheet: Anthrax Information for Health Care Providers (Centers for Disease Control and Prevention)
• Frequently Asked Questions About Anthrax (Centers for Disease Control and Prevention)
• Questions and Answers: Anthrax and Animal Hides (Centers for Disease Control and Prevention)
• Technical Information (Centers for Disease Control and Prevention)
• Clinical and Epidemiologic Principles of Anthrax (Centers for Disease Control and Prevention)
• Practical Information About Anthrax 196 KB (American Pharmaceutical Companies, April 11, 2002)

• Anthrax 326 KB (New York City Department of Health)

• Anthrax as a Biological Weapon, 2002: Updated Recommendations for Management 335 KB (Journal of the American Medical Association, May 1, 2002)
• Anthrax as a Biological Weapon 450 KB (Journal of the American Medical Association, May 12, 1999)
  

• Medical Treatment and Response to Suspected Anthrax: Information for Health Care Providers During Biologic Emergencies (New York City Department of Health, November 21, 2001) 130 KB
• Public Health Advisory for Clinicians 61.6 KB (New York State Department of Health, November 21, 2001)
• How to Arrange for Anthrax Testing 16.6 KB (New York State Department of Health, November 9, 2001)
• Clinical Evaluation of Patients with Possible Inhalational Anthrax 193 KB (created by the Center for the Study of Bioterrorism and Emerging Infections, original source MMWR November 2, 2001)
• Clinical Evaluation of Patients with Possible Cutaneous Anthrax 58.3 KB (created by the Center for the Study of Bioterrorism and Emerging Infections, original source MMWR November 2, 2001)
• Decontamination Advisory: Clean Up of Suspicious Powder/Substance (Anthrax Concern) 6.3 KB (New York State Department of Health, October 18, 2001)
• Protocol for Submitting Environmental Samples for Laboratory Testing 6.0 KB (New York State Department of Health, October 16, 2001)
• Criteria for Wadsworth Testing for Anthrax of Environmental Specimens 12.8 KB (New York State Department of Health, October 14, 2001)
• Guidelines on How to Handle Anthrax and Other Biological Agent Threats 784 KB (Centers for Disease Control and Prevention; October 14, 2001)
• Infectious Disease Society of America (IDSA) Bioterrorism Information and Resources

Bacillus Anthracis (anthrax)

• Medical Summary 
• Clinical Pathway
• Resources

• Update: Investigation of Bioterrorism — Related Anthrax and Adverse Events from Antimicrobial Prophylaxis (Centers for Disease Control and Prevention)
  

• Health Alert #4: Inhalational Anthrax in a New York City Resident who works with Unprocessed Animal Hides(New York City Department of Health and Mental Hygiene, February 22, 2006)
• New York State Department of Health "Dear Doctor" Letter 12.8 KB (October 19, 2001)
  • Attachment 1: Recognizing Illnesses that Might be Due to Bioterrorism 21.4 KB
  • Attachment 2: Recognizing Illnesses that Might be Due to Bioterrorism (Chart) 22.5 KB
  • Attachment 3: Fact Sheet on Anthrax 14.1 KB
  • Attachment 4: Anthrax as a Biological Weapon 450 KB (Journal of the American Medical Association Article, May 1999)
  • Attachment 5: Centers for Disease Control and Prevention Recommendations for the Prophylactic Use of Antibiotics for Anthrax 13.2 KB
  • Attachment 6: Web Site References 12.1 KB

• Anthrax (Centers for Disease Control and Prevention)